Crowdonomics
WatchlistPortfolio
GRYT HEALTH, INC

Reg CF · Preferred Stock · Jun 2024

ClosedReached targetReg CFPreferred Equity
via WeFunderView campaign
Raised
$78.6K / $750.5K max
10% of ceiling · target hit day 4
Investors
—
—
Post-money valuation
$18.1M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$1.5M$731K$0
29150
Jun 26, 2024 · openedApr 4, 2025 · last reading
Target ($55K) hit — Jun 30, 2024, day 4$1.0M raised — Oct 30, 2024Deadline Apr 30, 2025 — 26 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$2.5M
−$1.7M
FY2022
$2.2M
−$1.8M
FY2023
RevenueNet income
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$2,451,817
$2,228,199
Cost of goods sold
$0
$1,442,982
Gross margin
100%
35%
Net income
-$1,682,599
-$1,830,276
Taxes paid
-$192,674
$552,850
Balance sheet
Cash
$11,667
$368
Accounts receivable
$307,458
$277,971
Total assets
$1,116,268
$485,609
Short-term debt
$1,523,858
$314,982
Long-term debt
$0
$0
Total liabilities
$1,523,858
$314,982
Other
Headcount
—
18

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$18M
Post-money$18.1M
Price / share$7,817.59
Shares offered7

Offering details

Target$54,723
Max$750,489
Min investment$100
OpenedJun 26, 2024
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active308

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-24-000722

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.